Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

Project Details

Description

Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.
AcronymSRP48
StatusActive
Effective start/end date1/11/1731/10/22

Flemish discipline codes

  • Cancer therapy

Keywords

  • Dendritic Cells
  • Tonic Pain
  • Evoked Potentials
  • Bispecific Antibodies
  • Immunotherapy
  • Immunology
  • Oncology